{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:03:39Z","timestamp":1791147819296,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.ymgme.2008.12.002","type":"journal-article","created":{"date-parts":[[2009,1,19]],"date-time":"2009-01-19T09:30:35Z","timestamp":1232357435000},"page":"218-224","source":"Crossref","is-referenced-by-count":29,"title":["Discovery of a new biomarker for the mucopolysaccharidoses (MPS), dipeptidyl peptidase IV (DPP-IV; CD26), by SELDI-TOF mass spectrometry"],"prefix":"10.1016","volume":"96","author":[{"given":"Clare E.","family":"Beesley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth P.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niamh","family":"Finnegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Vellodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Cleary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan G.","family":"Winchester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2008.12.002_bib1","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3421","article-title":"The Mucopolysaccharidoses","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.ymgme.2008.12.002_bib2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jpeds.2004.01.046","article-title":"Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-l-iduronidase (laronidase)","volume":"144","author":"Wraith","year":"2004","journal-title":"J. Paediatr."},{"key":"10.1016\/j.ymgme.2008.12.002_bib3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ymgme.2006.09.001","article-title":"A phase I\/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome)","volume":"90","author":"Meunzer","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2008.12.002_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/08035320510028139","article-title":"Mucopolysaccharidosis VI Study Group, Pharmacokinetic profile of recombinant human N-acetylgalactosamine 4-sulphatase enzyme replacement therapy in patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): a phase I\/II study","volume":"94","author":"Harmatz","year":"2005","journal-title":"Acta. Paediatr. Suppl."},{"key":"10.1016\/j.ymgme.2008.12.002_bib5","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1172\/JCI117084","article-title":"Marked elevation of plasma chitotriosidase activity","volume":"93","author":"Hollak","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2008.12.002_bib6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood-2003-05-1612","article-title":"Marked elevation of the chemokine CCL18\/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention","volume":"103","author":"Boot","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2008.12.002_bib7","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1046\/j.1471-4159.1994.62051852.x","article-title":"Growth of ectopic dendrites on cortical pyramidal neurons in neuronal storage diseases correlates with abnormal accumulation of GM2 ganglioside","volume":"62","author":"Siegel","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2008.12.002_bib8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/cne.20355","article-title":"Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders","volume":"480","author":"McGlynn","year":"2004","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ymgme.2008.12.002_bib9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ymgme.2006.01.005","article-title":"Heparin cofactor II-thrombin complex in MPS I: a biomarker of MPS disease","volume":"88","author":"Randall","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2008.12.002_bib10","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ymgme.2008.05.001","article-title":"Heparin cofactor II-thrombin complex: a biomarker of MPS disease","volume":"94","author":"Randall","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2008.12.002_bib11","doi-asserted-by":"crossref","unstructured":"J. Dirosario, E. Divers, C. Wang, J. Etter, A. Charrier, P. Jukkola, H. Auer, V. Best, D.L. Newsom, D.M. McCarty, H. Fu, Innate and adaptive immune activation in the brain of MPS IIIB mouse model, J. Neurosci. Res. (2008) (Epub ahead of print).","DOI":"10.1002\/jnr.21912"},{"key":"10.1016\/j.ymgme.2008.12.002_bib12","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1515\/CCLM.2007.351","article-title":"Use of SELDI-TOF mass spectrometry for identification of new biomarkers: potential and limitations","volume":"45","author":"Kiehntopf","year":"2007","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.ymgme.2008.12.002_bib13","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0022-2275(20)32459-7","article-title":"Mass spectral study of polymorphism of the apolipoproteins of very low density lipoprotein","volume":"40","author":"Bondarenko","year":"1999","journal-title":"J. Lipid. Res."},{"key":"10.1016\/j.ymgme.2008.12.002_bib14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev.biochem.72.121801.161747","article-title":"Regulation of protein function by glycosaminoglycans\u2014as exemplified by chemokines","volume":"74","author":"Handel","year":"2005","journal-title":"Ann. Rev. Biochem."},{"key":"10.1016\/j.ymgme.2008.12.002_bib15","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nri1918","article-title":"The role of heparan sulphate in inflammation","volume":"6","author":"Parish","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymgme.2008.12.002_bib16","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1182\/blood-2005-02-0657","article-title":"Functional abnormalities of heparan sulfate in mucopolysaccharidosis-I are associated with defective biological activity of FGF-2 on human multipotent progenitor cells","volume":"106","author":"Pan","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2008.12.002_bib17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1365-3083.2001.00984.x","article-title":"CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes","volume":"54","author":"Gorrell","year":"2001","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.ymgme.2008.12.002_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1078\/0171-9335-00302","article-title":"The multifunctional or moonlighting protein CD26\/DPPIV","volume":"82","author":"Boonacker","year":"2003","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.ymgme.2008.12.002_bib19","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1365-2249.1994.tb06556.x","article-title":"Dipeptidyl peptidase IV (DP IV) activity in serum and on lymphocytes of MRL\/Mp-lpr\/lpr mice correlates with disease onset","volume":"96","author":"Kubota","year":"1994","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ymgme.2008.12.002_bib20","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.4049\/jimmunol.166.3.2041","article-title":"Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivo","volume":"166","author":"Steinbrecher","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymgme.2008.12.002_bib21","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1080\/003655201750313423","article-title":"Serum dipeptidyl peptidase IV (DPP IV, CD26) activity in chronic hepatitis C","volume":"36","author":"Firneisz","year":"2001","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.ymgme.2008.12.002_bib22","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1365-2362.2000.00698.x","article-title":"Elevated serum depeptidyl peptidase IV (CD26, EC 3.4.14.5) activity in experimental liver cirrhosis","volume":"30","author":"Lakatos","year":"2000","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2008.12.002_bib23","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1093\/clinchem\/34.12.2499","article-title":"Activity of dipeptidyl peptidase IV and post-proline cleaving enzyme in sera from osteoporotic patients","volume":"34","author":"Gotoh","year":"1988","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2008.12.002_bib24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.it.2008.02.010","article-title":"Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function","volume":"29","author":"Ohnuma","year":"2008","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ymgme.2008.12.002_bib25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/qjmed\/hch041","article-title":"Secondary skeletal involvement in Sanfilippo syndrome","volume":"97","author":"Rigante","year":"2004","journal-title":"QJM"},{"key":"10.1016\/j.ymgme.2008.12.002_bib26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00041433-200106000-00009","article-title":"Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism","volume":"12","author":"Shachter","year":"2001","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.ymgme.2008.12.002_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0167-0115(99)00089-0","article-title":"Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides","volume":"85","author":"Mentlein","year":"1999","journal-title":"Regul. Pept."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719208004526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719208004526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T04:51:47Z","timestamp":1632977507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719208004526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S1096719208004526"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2008.12.002","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}